IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $181,649,246 | +55.6% | 4,004,613 | +40.7% | 4.90% | +50.5% |
| Q2 2023 | $116,771,995 | +27.6% | 2,846,015 | +11.1% | 3.26% | -2.7% |
| Q1 2023 | $91,521,598 | +116.0% | 2,560,761 | +128.3% | 3.35% | +87.1% |
| Q4 2022 | $42,370,726 | -66.7% | 1,121,809 | -61.0% | 1.79% | -65.9% |
| Q3 2022 | $127,071,000 | +168.9% | 2,872,953 | +125.1% | 5.25% | +130.0% |
| Q2 2022 | $47,259,000 | -23.0% | 1,276,574 | -6.4% | 2.28% | -0.8% |
| Q1 2021 | $61,346,000 | -20.5% | 1,364,461 | 0.0% | 2.30% | -24.2% |
| Q4 2020 | $77,147,000 | +121.2% | 1,364,461 | +85.6% | 3.04% | +59.7% |
| Q3 2020 | $34,878,000 | -58.4% | 735,055 | -48.3% | 1.90% | -63.3% |
| Q2 2020 | $83,891,000 | -8.8% | 1,422,842 | -26.8% | 5.17% | -39.6% |
| Q1 2020 | $91,937,000 | -30.2% | 1,944,517 | -10.8% | 8.57% | -14.2% |
| Q4 2019 | $131,678,000 | +134.9% | 2,179,735 | +133.0% | 9.98% | +69.5% |
| Q3 2019 | $56,049,000 | +10933.3% | 935,548 | +9853.7% | 5.89% | +8822.7% |
| Q4 2018 | $508,000 | -98.1% | 9,399 | -98.2% | 0.07% | -97.2% |
| Q3 2018 | $26,822,000 | +12.9% | 520,000 | -8.8% | 2.36% | +1.7% |
| Q2 2018 | $23,752,000 | +20.0% | 570,000 | -32.9% | 2.32% | -45.0% |
| Q2 2016 | $19,797,000 | – | 850,000 | – | 4.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |